Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Up 9.3% – Here’s Why

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) rose 9.3% during trading on Monday . The stock traded as high as $17.29 and last traded at $17.29. Approximately 666 shares were traded during trading, a decline of 96% from the average daily volume of 17,672 shares. The stock had previously closed at $15.82.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on TLX shares. UBS Group began coverage on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research report on Friday, November 15th. They issued a “buy” rating and a $21.00 price objective on the stock. William Blair raised Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a report on Tuesday, November 19th.

Telix Pharmaceuticals Limited American Depositary Shares Price Performance

About Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.